The Akt-Specific Inhibitor MK2206 Selectively Inhibits Thyroid Cancer Cells Harboring Mutations That Can Activate the PI3K/Akt Pathway

Ítems similars

• The Akt-Specific Inhibitor MK2206 Selectively Inhibits Thyroid Cancer Cells Harboring Mutations That Can Activate the PI3K/Akt Pathway
  per: Liu, Ruixin, et al.
  Publicat: (2011)
• The Akt Inhibitor MK2206 Synergizes, but Perifosine Antagonizes, the BRAF(V600E) Inhibitor PLX4032 and the MEK1/2 Inhibitor AZD6244 in the Inhibition of Thyroid Cancer Cells
  per: Liu, Ruixin, et al.
  Publicat: (2012)
• Identification of RASAL1 as a Major Tumor Suppressor Gene in Thyroid Cancer
  per: Liu, Dingxie, et al.
  Publicat: (2013)
• Genetic Alterations in the PI3K/Akt Signaling Pathway Confer Sensitivity of Thyroid Cancer Cells to Therapeutic Targeting of Akt and mTOR
  per: Liu, Dingxie, et al.
  Publicat: (2009)
• IQGAP1 Plays an Important Role in the Invasiveness of Thyroid Cancer
  per: Liu, Zhi, et al.
  Publicat: (2010)